UBS/CALL/PFIZER INC/43/0.1/20.12.24 | Delayed Deutsche Boerse AG 13:33:30 2024-06-26 EDT | ||
| 0.001 EUR | 0.00% |
|
| 1 month | -83.33% | ||
| 3 months | -87.50% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
PFIZER, INC.
Latest news about PFIZER, INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-06-26 | 0.001 | 0.00% |
| 24-06-25 | 0.001 | -75.00% |
| 24-06-24 | 0.004 | 0.00% |
| 24-06-21 | 0.004 | -20.00% |
| 24-06-20 | 0.005 | 0.00% |
Delayed Quote Deutsche Boerse AG
Last update June 26, 2024 at 01:33 pm
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | PFIZER, INC. |
| Issuer | UBS |
| WKN | UL1VQY |
| ISIN | CH1227466831 |
| Date issued | 2023-02-21 |
| Strike | 43 $ |
| Maturity | 2024-12-20 (177 Days) |
| Parity | 10 : 1 |
| Emission price | 0.6 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.59 € |
|---|---|
| Lowest since issue | 0.001 € |
| Spread | 0.03 € |
| Spread % | 96.77% |
Company Profile
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows:
- primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.;
- specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.;
- oncology products (12.1%);
- other (1.3%).
At the end of 2022, the group had more than 35 manufacturing sites worldwide.
Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
Consensus: Pfizer, Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
27.99
USD
Average target price
31.92
USD
Spread / Average Target
+14.02%
- Stock Market
- Warrants
- Warrant
